Al-Wahaibi Lamya H, Rahul Bavanandan, Mohamed Ahmed A B, Abdelbaky Mohammed S M, Garcia-Granda Santiago, El-Emam Ali A, Percino M Judith, Thamotharan Subbiah
Department of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia.
Biomolecular Crystallography Laboratory, Department of Bioinformatics, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur 613 401, India.
ACS Omega. 2021 Mar 3;6(10):6996-7007. doi: 10.1021/acsomega.0c06287. eCollection 2021 Mar 16.
A selective triazole-based COX-2 inhibitor, 4-(4-chlorophenyl)-3-[(4-fluorobenzyl)sulfanyl]-5-(thiophen-2-yl)-4-1,2,4-triazole, CHClFNS, has been synthesized, and its crystal structure was determined at 150 K. Single-crystal X-ray diffraction analysis revealed that the thiophene ring was disordered over two orientations. The crystal structure is stabilized by weak hydrogen and chalcogen bonds and unorthodox F···π and S···C(π) contacts. These noncovalent interactions cooperatively generate the supramolecular self-assembly in the crystalline state. The Hirshfeld surface and its associated two-dimensional (2D)-fingerprint plots were obtained to analyze the role of different noncovalent interactions in the crystal packing. Further, the enrichment ratio was obtained from different atom···atom pairs to calculate the propensity of these pairs to form noncovalent interactions. The strength of different dimeric motifs formed in the crystal structure and lattice energies was calculated by the PIXEL method. Furthermore, the topological analysis of the charge density of intermolecular interactions was described. A CSD survey of C-H···F hydrogen bond, C-S···Cl chalcogen bond, and unorthodox nonbonded contacts (F···π and S···C(π)) is presented. The title compound possesses selective inhibitory activity against human COX-2 enzyme rather than COX-1. The quantum mechanics (QM) polarized ligand docking analysis was used to predict the binding pose and study the title compound's selectivity against COX-1/2 enzymes.
一种基于三唑的选择性COX-2抑制剂,4-(4-氯苯基)-3-[(4-氟苄基)硫烷基]-5-(噻吩-2-基)-4H-1,2,4-三唑,CHClFNS,已被合成,并在150 K下测定了其晶体结构。单晶X射线衍射分析表明,噻吩环在两个取向上无序。晶体结构通过弱氢键和硫族元素键以及非传统的F···π和S···C(π)接触得以稳定。这些非共价相互作用协同在晶体状态下产生超分子自组装。获得了Hirshfeld表面及其相关的二维(2D)指纹图谱,以分析不同非共价相互作用在晶体堆积中的作用。此外,从不同的原子···原子对获得富集率,以计算这些对形成非共价相互作用的倾向。通过PIXEL方法计算了晶体结构中形成的不同二聚体基序的强度和晶格能。此外,还描述了分子间相互作用电荷密度的拓扑分析。对C-H···F氢键、C-S···Cl硫族元素键和非传统非键接触(F···π和S···C(π))进行了CSD调查。标题化合物对人COX-2酶而非COX-1具有选择性抑制活性。使用量子力学(QM)极化配体对接分析来预测结合姿势并研究标题化合物对COX-1/2酶的选择性。